HUMA - Humacyte - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HUMA is currently covered by 6 analysts with an average price target of $8.13. This is a potential upside of $7.14 (1326.32%) from yesterday's end of day stock price of $0.57.

Humacyte's activity chart (see below) currently has 60 price targets and 101 ratings on display. The stock rating distribution of HUMA is 97.06% BUY and 2.94% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.56% with an average time for these price targets to be met of 92 days.

Highest price target for HUMA is $25, Lowest price target is $1.5, average price target is $8.13.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 11-Jun-2026. First documented stock forecast 20-Jul-2021.

Currently out of the existing stock ratings of HUMA, 33 are a BUY (97.06%), 1 are a HOLD (2.94%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-May-2025

$4

$2.94 (277.36%)

$3

3 months 2 days ago
(11-Jun-2026)

0/4 (0%)

$2.92 (270.37%)

Buy Since 23-Sep-2021

$2

$0.94 (88.68%)

$3

3 months 5 days ago
(08-Jun-2026)

2/15 (13.33%)

$0.62 (44.93%)

409

Buy Since 29-Oct-2021

$1.5

$0.44 (41.51%)

$1

3 months 30 days ago
(14-May-2026)

3/12 (25%)

$0.5 (50.00%)

29

Buy Since 09-Sep-2024

$25

$23.94 (2258.49%)

$25

4 months 16 days ago
(28-Apr-2026)

0/7 (0%)

$24.15 (2841.18%)

Buy Since 20-Jul-2021

1 years 3 months 30 days ago
(14-May-2025)

0/12 (0%)

$12.35 (265.59%)

Show more analysts

Please expand the browser size to see the chart

What is HUMA (Humacyte) average time for price targets to be met?

On average it took 92 days for the stock forecasts to be reached, with an average price target met ratio of 21.56%.

Which analyst most recently updated their price target on HUMA (Humacyte)?

Swayampakula Ramakanth

Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on HUMA (Humacyte)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 4 price targets and 10 ratings on HUMA

Which analyst is the currently most bullish on HUMA (Humacyte)?

Jason Kolbert with the highest potential upside of $23.94

Which analyst is the currently most reserved on HUMA (Humacyte)?

Matt O'brien with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?